Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Eupraxia Pharmaceuticals Inc./ 6-K

SEC Filing · 6-K

Eupraxia Pharmaceuticals Inc.

SEC Filing

Filed Sep 8, 2026Accepted Sep 8, 2026, 8:05 AM EDTCIK 1581178Accession 0001171843-26-005913
View company →Permanent SEC source ↗
Share

Company context

Current securities

EPRXNASDAQ · EQUITY · CurrentEPRXTSX · EQUITY · Current
Historical securities (3)
EPRXFOTC · EQUITY · Historical · closed Apr 3, 2024EPRX.WTTSX · WARRANT · Historical · closed Mar 9, 2026EPRX.WT.ATSX · WARRANT · Historical · closed Apr 20, 2026

Recent company filings

  1. SUPPL filingSep 2, 2026
  2. EFFECT filingAug 24, 2026
  3. F-10/A filingAug 19, 2026
  4. 6-K filingAug 13, 2026
  5. 6-K filingAug 11, 2026

As-filed source

Primary evidence
As filedOpen full document ↗